Order Article Reprints

Canale M, Petracci E, Delmonte A, Bronte G, Chiadini E, Ludovini V, Dubini A, Papi M, Baglivo S, De Luigi N, et al. Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs. Journal of Clinical Medicine. 2020; 9(4):1047. https://doi.org/10.3390/jcm9041047

Canale, Matteo, Elisabetta Petracci, Angelo Delmonte, Giuseppe Bronte, Elisa Chiadini, Vienna Ludovini, Alessandra Dubini, Maximilian Papi, Sara Baglivo, Nicoletta De Luigi, and et al. 2020. "Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs" Journal of Clinical Medicine 9, no. 4: 1047. https://doi.org/10.3390/jcm9041047

Canale, M., Petracci, E., Delmonte, A., Bronte, G., Chiadini, E., Ludovini, V., Dubini, A., Papi, M., Baglivo, S., De Luigi, N., Verlicchi, A., Chiari, R., Landi, L., Metro, G., Burgio, M. A., Crinò, L., & Ulivi, P. (2020). Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs. Journal of Clinical Medicine, 9(4), 1047. https://doi.org/10.3390/jcm9041047